Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism-Reference-Cited by-同舟云学术

Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism

Published:2019-01 Issue:1 Volume:103 Page:168-176
ISSN:1534-6080
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Oura Tetsu,Hotta Kiyohiko,Rosales Ivy,Dehnadi Abbas,Kawai Kent,Lee Hang,Benedict Cosimi A.,Kawai Tatsuo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference34 articles.

1. Use of CTLA4Ig for Induction of Mixed Chimerism and Renal Allograft Tolerance in Nonhuman Primates;Am J Transplant,2014

2. Long-term nonhuman primate renal allograft survival without ongoing immunosuppression in recipients of delayed donor bone marrow transplantation;Transplantation,2018

3. Immunosuppression with CD40 costimulatory blockade plus rapamycin for simultaneous islet and kidney transplantation in nonhuman primates;Am J Transplant,2016

4. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates;Am J Transplant,2012

5. Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation;J Immunol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to induce tolerance;Living Donor Organ Transplantation;2024

2. Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms;Transplantation;2023-04-13

3. Current Topics of Relevance to the Xenotransplantation of Free Pig Islets;Frontiers in Immunology;2022-04-01

4. Molecular cloning of duck CD40 and its immune function research;Poultry Science;2021-06

5. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance;Frontiers in Immunology;2021-02-26